Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Deal Watch: Allergan Deal-Binge Includes Derm, NASH Buys

Executive Summary

Golden Meditech and MD Anderson establish startup focused on umbilical cord blood-derived T-regulatory therapies. Bayer and Evotec sign their second collaboration in four years, this time focused on renal disease.

Advertisement

Related Content

Refocusing Tarveda On Tumor-Targeted Mini-Drug Conjugates
Genentech, BioNTech Pact Aims To Make Targeted Cancer Vaccines
Viventia's Cancer Ambitions Go To Eleven
Allergan’s Tab For Tobira’s NASH Cocktail With Akarna Chaser Tops $1.7bn
Bayer Reiterates Pharma Commitment Post-Monsanto, Plays Up Pipeline
Regeneron Partners NGF Antibody With Teva To Mitigate Risks
Pfizer Is Back In The CTLA-4 Game Via Pact With OncoImmune
Could $639m Vitae Buy Give Allergan A New Autoimmune Focus?
The NASH Pipeline: Replete With Targets And New Compounds
Tobira Says Secondary Endpoint In NASH Will Carry CVC Into Pivotal Study

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC097344

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel